Endonovo Therapeutics Inc (ENDV)

[Craig305]

Did a little history investigation of Sofpulse.

Aug. 1998 - ADM Tronics acquires Sofpulse assets.

April 2005 - Ivivi (a subsidiary of ADM) introduces the next generation of Sofpulse (New and improved version).

Dec. 2008 - FDA gives clearance to Ivivi for 3 models of Sofpulse.

Sep. 2009 - Ivivi sells some assets to Steve Gluckstern (CEO of Rio Grande..although RGN is not mentioned in PR). The assets are not specifically mentioned but this creates business relationship between the companies.

SEP 2015 - Rio Grande acquires Ivivi's tPEMF technology. RGN was previously licensing the use of it.

Seems ADM Tronics is doing the manufacturing and logistics of the device.

This device has been around in it's current FDA approved form since end of 2008?
Has it been a victim of mismanagement?

I can understand Ivivi's challenge of handling it during the financial crisis of 2007-2008 and then the delay of FDA approval.

What is Rio Grande's excuse for sitting on it during the years afterwards? That's a long time to sit on a FDA approved device.

Let's see if Endonovo can market a FDA approved device that is years old and never created a big buzz in the medical community.

I did see an article from Aetna (believe dated April 2017) stating they are aware of the device but it has a lack of published data on it's effectiveness.

Endonovo...are you reading this?
Learn from past mistakes.